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Background. Valvular heart disease (VHD) affects the population of different age, regardless 
of their etiology has a lot of complications and death. Rheumatic ethiology was reported in 40 
% of valvulopathy and is frequently associated with atrial fibrilation (4.5%), trombembolic 
complication (5.9%) and infectious endocarditis (5.8%). Early risk assessment is required to 
increases the chances to avoid unwanted effects of diseases.  
Case report. A 49-year-old female with complains of dyspnoea at minimal effort, palpitations, 
low tolerance at fizical activity. From the history of the disease is known that in childhood she 
suffered rheumatic fever. In 1999 was found mitral stenosis and performed mitral 
commissurotomy, in 2005 - mitral valve replacement and tricuspid valve annuloplasty. In 2006 
-paroxysmal atrial fibrillation. In 2005, 2008, 2011- ischemic stroke. In 2008 - infectious 
endocarditis of mitral valve prosthesis. The patient is given permanent treatment with: 
„Acenocoumarol”, ”Spironolactona”, ”Torasemid”, ”Amiodarone”. On examination: heart rate 
64 b/min, BP -120/60mmHg. Laboratory: dyslipidemia, on ecocardiography: moderate 
enlargement of left ventricular diameter and left atrium, mitral regurgitation II degree, aortic – 
II degree, tricuspid – II degree, pulmonar- II degree.  
Conclusions. This 49-year-old patient suffered by valvular heart diseases, complicated with 
infectious endocarditis, paroxysmal atrial fibrillation and three episodes of ischemic stroke 
which worsened the quality of patient`s life. The prevention and management of these 
complications requires an understanding of their origin with the aim of to balance the risks 
wich related with valvular disease and benefits associated with treatment.  
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Introduction. Left ventricular hypertrophy is an important predictor for cardiovascular 
mortality and morbidity. ECG is the most accessible method of LVH diagnosis, but has a low 
sensibility. It's detection still remains an important factor that contributes to cardiovascular risk 
stratification.  
Aim of the study. The aim of the study is to evaluate the prevelance of different ECG criteria 
for left ventricular hypertrophy diagnosis in common population.  
Materials and methods. A comprehensive systematic search of studies published in different 
datebases like MEDLINE, EMBASE and Scopus were selected.The main inclusion criteria was 
the research of Sokolow-Lyon, Cornell index, Romhilt-Estes and RaVL ECG criteria.  
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Results. 4 studies were indentified to correspond inclusion criteria.The included studies 
comprised 2209 patients.The sensibility of selected criteria are: Sokolow-Lyon 10-27%, 
Cornell index 23-45%, Romhilt-Estes 24-49%, RaVL 8-26%. The revealed heterogeneity is 
due to differences of pupulation groups such as age, gender,race and presence of comorbidities   
Conclusions. The findings of this study revealed that Romhilt-Estes score is the most relevant 
ECG criteria for left ventricular hypertrophy diagnosis for common population.  
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Romhilt-Estes score, RaVL.  
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Introduction. -Identification of risk factors of FA and development of stroke. Identification of 
the presence of comorbidities among the analyzed patients. Estimation of the degree of cerebral 
impairment in stroke with FA / without FA. Determination of the degree of compliance and 
therapeutic control in patients with AF. Analysis of neurocognitive disorders through MMES 
(Mini test for mental health examination).  
Aim of the study. Assessment of the impact of non-valvular AF on cardioembolic stroke 
production and impaired cognitive ability.  
Materials and methods. The study was performed on a number of 60 stroke patients, from: 
The Sfânta Trime Municipal Clinical Hospital and the Institute of Emergency Medicine.  
Results. In group 1, two age categories prevailed, 61-70 years (55%) and 81-91 years (15%) 
and a higher incidence of women (80%). Risk factors were: obesity (60%), stress (33.3%), 
sedentary lifestyle (26.6%), smoking (6.67%), alcohol consumption (13.3%) and hereditary 
factor (33 ,3%).  In group 2, patients between the ages of 61-70 years (63.3%) predominated, 
more often the male sex (53.3%), the risk factors being: smoking (53.3%) with an index of 20 
packs / year, alcohol consumption (16.6%), obesity (60%), stress (33.3%), sedentary lifestyle 
(40%) and hereditary factor (13.3%).   The comorbidities present in the patients included in the 
study were: CI (61.67%), DZ tpi II (21.7%), HTA (86.6%), PA (26.6%), CPI (60%), IM 
(1.6%), BCR (11.6%), cancer (1.66%) and Dyslipidemia (33.3%).  
Conclusions. 314/5000 The study argues the need to prevent thromobembolic complications 
through drug control with aticoagulants and to maintain the INR in the therapeutic window in 
patients with AF.   Information and education of patients on a large scale in order to achieve a 
better treatment compliance.  
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